These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 229130

  • 1. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
    Heald J, Buckley CH, Fox H.
    J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
    [Abstract] [Full Text] [Related]

  • 2. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.
    Khoo SK, MacKay EV.
    Br J Obstet Gynaecol; 1976 Oct; 83(10):753-9. PubMed ID: 990213
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A, Bar JK, Jothy S, Sedlaczek P, Slesak B, Richter R.
    Tumour Biol; 1993 Oct; 14(1):1-8. PubMed ID: 7684152
    [Abstract] [Full Text] [Related]

  • 5. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
    Melnick H, Barber HR.
    Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
    Gogate N, Deshmukh S.
    Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
    [Abstract] [Full Text] [Related]

  • 7. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A, Slesak B, Richter R, Rabczyński J, Cisło M.
    Cancer Detect Prev; 1986 Apr; 9(3-4):347-58. PubMed ID: 3017557
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T, Maruo T, Iwasaki M, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [Abstract] [Full Text] [Related]

  • 10. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ, Fullerton WT, Klopper A.
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A, Fenoglio CM, Pascal R, Richart RM, Bennett S.
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML, Selkäinaho K, Collan Y.
    Appl Pathol; 1986 Dec; 4(1-2):83-9. PubMed ID: 3034311
    [Abstract] [Full Text] [Related]

  • 14. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
    Maughan TS, Fish RG, Shelley M, Jasani B, Williams GT, Adams M.
    Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
    Ueda S, Tsubura A, Izumi H, Sasaki M, Morii S.
    Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
    [Abstract] [Full Text] [Related]

  • 16. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A, Yakushiji M.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan 20; 25(1):47-54. PubMed ID: 2157782
    [Abstract] [Full Text] [Related]

  • 17. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.
    Charpin C, Bhan AK, Zurawski VR, Scully RE.
    Int J Gynecol Pathol; 1982 Jan 20; 1(3):231-45. PubMed ID: 6193072
    [Abstract] [Full Text] [Related]

  • 18. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR, Pletsch QA, Goldenberg DM.
    Cancer Res; 1975 Jun 20; 35(6):1433-7. PubMed ID: 805659
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
    Kato T, Nishimura H, Hamai J, Yamabe T, Nakajima H, Nakano T, Noda K, Teshima K, Suzuki H, Ueda G.
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec 20; 20(10):2338-45. PubMed ID: 3007640
    [No Abstract] [Full Text] [Related]

  • 20. Intestine-associated antigens in ovarian tumours: an immunohistological study.
    De Boer WG, Ma J, Nayman J.
    Pathology; 1981 Jul 20; 13(3):547-55. PubMed ID: 7029434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.